Luminal ANG II is internalized as a complex with AT1R/AT2R heterodimers to target endoplasmic reticulum in LLC-PK1 cells

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F440-F449. doi: 10.1152/ajprenal.00261.2016. Epub 2017 May 3.

Abstract

ANG II has many biological effects in renal physiology, particularly in Ca2+ handling in the regulation of fluid and solute reabsorption. It involves the systemic endocrine renin-angiotensin system (RAS), but tissue and intracrine ANG II are also known. We have shown that ANG II induces heterodimerization of its AT1 and AT2 receptors (AT1R and AT2R) to stimulate sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) activity. Thus, we investigated whether ANG II-AT1R/AT2R complex is formed and internalized, and also examined the intracellular localization of this complex to determine how its effect might be exerted on renal intracrine RAS. Living cell imaging of LLC-PK1 cells, quantification of extracellular ANG II, and use of the receptor antagonists, losartan and PD123319, showed that ANG II is internalized with AT1R/AT2R heterodimers as a complex in a microtubule-dependent and clathrin-independent manner, since colchicine-but not Pitstop2-blocked this process. This result was confirmed by an increase of β-arrestin phosphorylation after ANG II treatment, clathrin-mediated endocytosis being dependent on dephosphorylation of β-arrestin. Internalized ANG II colocalized with an endoplasmic reticulum (ER) marker and increased levels of AT1R, AT2R, and PKCα in ER-enriched membrane fractions. This novel evidence suggests the internalization of an ANG II-AT1/AT2 complex to target ER, where it might trigger intracellular Ca2+ responses.

Keywords: ANG II-AT1R/AT2R complex; ANG II-AT1R/AT2R internalization; LLC-PK1 luminal membranes; endoplasmic reticulum; microtubule-dependent clathrin-independent endocytosis.

MeSH terms

  • Angiotensin II / metabolism*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Angiotensin II Type 2 Receptor Blockers / pharmacology
  • Animals
  • Calcium / metabolism
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Endocytosis* / drug effects
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / metabolism*
  • Kidney / drug effects
  • Kidney / metabolism*
  • LLC-PK1 Cells
  • Microtubules / metabolism
  • Multiprotein Complexes
  • Phosphorylation
  • Protein Kinase C-alpha / metabolism
  • Protein Transport
  • Receptor, Angiotensin, Type 1 / drug effects
  • Receptor, Angiotensin, Type 1 / metabolism*
  • Receptor, Angiotensin, Type 2 / drug effects
  • Receptor, Angiotensin, Type 2 / metabolism*
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism
  • Swine
  • beta-Arrestins / metabolism

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin II Type 2 Receptor Blockers
  • Multiprotein Complexes
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • beta-Arrestins
  • Angiotensin II
  • Protein Kinase C-alpha
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Calcium